62
H.-F. Jiang, J.-W. Zhao / Tetrahedron Letters 50 (2009) 60–62
(8), 41 (5). 4-Benzylidene-3-sec-butyl-5-butyl-5-ethyloxazolidin-2-one (3b, Z/E
mixture): IR (KBr,
/cmÀ1): 2968, 2934, 2875, 1760, 1666; 1H NMR (400 MHz,
intermediate formed via the intramolecular cyclization of 6, could
be alternatively eliminated, and Z/E ratio in the products almost
rested with stochastic process.
In conclusion, we have shown that internal propargylic alcohols
can be activated for the cycloaddition reaction with primary
amines and carbon dioxide under supercritical condition catalyzed
by silver salt to afford 4-alkylidene-1,3-oxazolidin-2-ones. Other
efficient chemical fixations of carbon dioxide into useful fine
chemicals are explored in our laboratory.
m
CDCl3) d (ppm): 0.85–0.89 (m, 3H), 0.94–0.99 (m, 6H), 1.36–1.45 (m, 7H), 1.63–
1.69 (m, 6H), 3.42–3.46 (t, J = 7.6 Hz, 1H), [3.91–3.95 (t, J = 7.8 Hz, 1H)], 5.32 (s,
1H), [5.94 (s, 1H)], 7.12–7.18 (m, 3H), 7.25–7.31 (m, 2H); 13C NMR (100 MHz,
CDCl3) d (ppm): 6.3, 10.4, 13.0, 16.0, 21.5, 23.8, 24.9, 31.1, 37.8, 50.6, 86.5, 98.5,
126.1, 127.1, 128.4, 134.3, 139.8, 154.9; MS (EI, 70 eV): m/z (%) = 315 [M+] (32),
259 (100), 244 (22), 224 (21), 202 (32), 180 (25), 145 (8), 117 (15), 91 (16), 57
(8), 41 (5). 3-Allyl-4-benzylidene-5-butyl-5-ethyloxazolidin-2-one (3c, Z/E
mixture): IR (KBr, m
/cmÀ1): 2959, 2931, 2873, 1742, 1673; 1H NMR (400 MHz,
CDCl3) d (ppm): 0.89–0.93 (m, 3H), 0.95–0.98 (m, 3H), 1.34–1.38 (m, 4H), 1.62–
1.70 (m, 3H), 3.93–3.97 (t, J = 7.8 Hz, 2H), 4.59–4.63 (q, J = 5.4 Hz, 1H), 4.89–4.92
(q, J = 5.4 Hz, 1H), 5.29–5.35 (m, 1H), 5.40 (s, 1H), [5.81 (s, 1H)], 7.16–7.22 (m,
3H), 7.25–7.30 (m, 2H); 13C NMR (100 MHz, CDCl3) d (ppm): 6.26, 13.0, 21.7,
24.0, 32.4, 39.1, 44.6, 86.8, 97.2, 116.9, 125.9, 126.9, 128.9, 130.4, 134.0, 138.9,
156.3; MS (EI, 70 eV): m/z (%) = 299 [M+] (34), 243 (100), 228 (22), 208 (16), 186
(8), 164 (14), 131 (8), 116 (15), 91 (12), 57 (15), 41 (12). 4-Benzylidene-5-butyl-3-
cyclohexyl-5-ethyloxazolidin-2-one (3d, Z/E mixture): IR (KBr, v/cmÀ1): 2957,
2931, 2858, 1761, 1665; 1H NMR (400 MHz, CDCl3) d (ppm): 0.83–0.91 (m, 6H),
1.32–1.38 (m, 8H), 1.57–1.85 (m, 10H), 3.15–3.19 (t, J = 7.8 Hz, 1H), [3.62–3.66
(t, J = 7.4 Hz, 1H)], 5.34 (s, 1H), [6.00 (s, 1H)], 7.12–7.19 (m, 3H), 7.25–7.30 (m,
2H); 13C NMR (100 MHz, CDCl3) d (ppm): 6.1, 13.0, 21.5, 23.9, 25.2, 27.6, 31.2,
37.7, 52.9, 86.4, 98.3, 126.1, 127.1, 128.5, 134.3, 139.7, 154.8; MS (EI, 70 eV): m/z
(%) = 341 [M+] (38), 285 (64), 260 (90), 230 (50), 203 (100), 168 (28), 124 (34), 91
(42), 57 (15), 55 (52), 41 (24), 28 (39). 4-Benzylidene-5-butyl-5-ethyl-3-
hexyloxazolidin-2-one (3e, Z/E mixture): IR (KBr, v/cmÀ1): 2958, 2931, 2861,
1767, 1671; 1H NMR (400 MHz, CDCl3) d (ppm): 0.72–0.76 (m, 3H), 0.82–0.89
(m, 6H), 1.30–1.36 (m, 10H), 1.63–1.65 (m, 6H), 3.24–3.29 (t, J = 7.2 Hz, 2H),
[3.50–3.54 (t, J = 7.8 Hz, 2H)], 5.32 (s, 1H), [5.94 (s, 1H)], 7.12–7.17 (m, 3H),
7.23–7.31 (m, 2H); 13C NMR (100 MHz, CDCl3) d (ppm): 7.1, 13.9, 22.5, 24.9,
26.1, 26.5, 31.5, 31.9, 33.3,41.3, 88.4, 99.0, 127.0, 128.1, 129.3, 134.9, 140.5,
156.3; MS (EI, 70 eV): m/z (%) = 343 [M+] (34), 287 (100), 252 (25), 230 (35), 202
(34), 188 (22), 131 (15), 117 (26), 91 (44), 55 (18), 43 (32), 28 (38). 4-
Benzylidene-3-butyl-5,5-pentamethyleneoxazolidin -2-one (3f, Z/E mixture): IR
(KBr, v/cmÀ1): 2964, 2935, 2866, 1761, 1686: 1H NMR (400 MHz, CDCl3) d
(ppm): 0.56–0.60 (m, 3H), 0.93–0.97 (m, 2H), 1.58–1.63 (m, 10H), 1.69–1.77 (m,
2H), 3.25–3.28 (m, 2H), [3.49–3.53 (t, J = 7.4 Hz, 2H)], 5.45 (s, 1H), [5.71 (s, 1H)],
7.13–7.19 (m, 3H), 7.21–7.32 (m, 2H); 13C NMR (100 MHz, CDCl3) d (ppm): 13.4,
19.2, 21.8, 24.7, 28.9, 37.3, 42.6, 83.9, 98.0, 126.7, 127.8, 129.6, 134.9, 143.2,
156.8; MS (EI, 70 eV): m/z (%) = 299 [M+] (100), 257 (22), 244 (54), 200 (16), 172
(26), 129 (10), 117 (15), 91 (22), 81 (14), 41 (6). 3-Butyl-4-ethylidene-5,5-
pentamethyleneoxazolidin-2-one (3g, Z/E mixture): IR (KBr, v/cmÀ1): 2961, 2934,
2864, 1764, 1671; 1H NMR (400 MHz, CDCl3) d (ppm): 0.88–0.92 (t, J = 7.4 Hz,
3H), 1.26–1.30 (t, J = 7.8 Hz, 3H), 1.48–1.50 (d, J = 7.6 Hz, 2H),1.62–1.90 (m,
12H), 3.33–3.37 (t, J = 7.4 Hz, 2H), [3.59–3.63 (t, J = 7.6 Hz, 2H)], 4.17–3.23 (t,
J = 7.6 Hz, 1H), [4.41–4.46 (t, J = 7.4 Hz, 1H)]; 13C NMR (100 MHz, CDCl3) d
(ppm): 11.5, 13.7, 19.7, 21.5, 24.7, 28.3, 34.1, 40.7, 83.5, 91.7, 141.6, 155.7; MS
(EI, 70 eV): m/z (%) = 237 [M+] (55), 208 (24), 195 (44), 182 (100), 164(22), 150
(28), 138 (32), 122 (32), 108 (18), 93 (14), 81 (16), 55 (14), 41 (12), 28(8).
4-Benzylidene-3-butyloxazolidin-2-one (3h, Z/E mixture): IR (KBr, v/cmÀ1): 2959,
2934, 2873, 1771, 1661; 1H NMR (400 MHz, CDCl3) d (ppm): 0.96–1.00 (t,
J = 7.4 Hz, 3H), 1.37–1.46 (m, 2H), 1.63–1.71 (m, 2H), 3.36–3.40 (t, J = 7.6 Hz,
2H), [3.56–3.960 (t, J = 7.4 Hz, 1H)], 4.46 (s, 2H), [5.14 (d, J = 2.8 Hz, 2H)], 5.65 (s,
1H), [6.46 (s, 1H)], 7.16–7.20 (m, 3H), 7.25–7.32 (m, 2H); 13C NMR (100 MHz,
CDCl3) d (ppm): 12.8, 19.1, 27.6, 40.6, 66.1, 98.7, 124.8, 126.0, 128.0, 134.5,
134.9, 155.9; MS (EI, 70 eV): m/z (%) = 231 [M+] (100), 201 (24), 174 (32), 161
(18), 130 (20), 118 (38), 91 (72), 78 (20), 41 (12). 4-Benzylidene-3-butyl-5-
methyloxazolidin-2-one (3i, Z/E mixture): IR (KBr, v/cmÀ1): 2960, 2934, 2873,
1770, 1667; 1H NMR (400 MHz, CDCl3) d (ppm): 0.96–0.99 (t, J = 7.4 Hz, 3H),
1.37–1.45 (m, 2H), 1.62–1.69 (m, 5H), 3.49–3.62 (m, 2H), 5.60 (d, J = 2.8 Hz, 1H),
5.64–5.69 (m, 1H), 7.14–7.19 (m, 3H), 7.25–7.33 (m, 2H); 13C NMR (100 MHz,
CDCl3) d (ppm): 12.8, 17.9, 19.1, 27.6, 40.3, 73.5, 98.3, 125.2, 126.8, 127.8, 134.2,
140.0, 155.3; MS (EI, 70 eV): m/z (%) = 245 [M+] (100), 190 (40), 145 (32), 130
(34), 117(60), 91 (75), 28 (20).
Acknowledgments
The authors thank the National Natural Science Foundation of
China (Nos. 20772034, 20625205, 20572027 and 20332030) and
Guangdong Natural Science Foundation (No. 07118070) for finan-
cial support of this work.
References and notes
1. (a) Yoshida, H.; Fukushima, H.; Ohshita, J.; Kunai, A. J. Am. Chem. Soc. 2006, 128,
11040; (b) Himeda, Y.; Onozawa-Komatsuzaki, N.; Sugihara, H.; Kasuga, K. J. Am.
Chem. Soc. 2005, 127, 13118; (c) Ohnishi, Y. Y.; Matsunaga, T.; Nakao, Y.; Sato, H.;
Sakaki, S. J. Am. Chem. Soc. 2005, 127, 4021; (d) Darensbourg, D. J. Chem. Rev.
2007, 107, 2388; (e) Sakakura, T.; Choi, J. C.; Yasuda, H. Chem. Rev. 2007, 107,
2365.
2. (a) Mukhtar, T. A.; Wright, G. D. Chem. Rev. 2005, 105, 529; (b) Aurelio, L.;
Brownlee, R. T. C.; Hughes, A. B. Chem. Rev. 2004, 104, 5823; (a) Chung, C. W. Y.;
Toy, P. H. Tetrahedron: Asymmetry 2004, 15, 387; (d) Ager, D. J.; Prakash, I.;
Schaad, D. R. Chem. Rev. 1996, 96, 835.
3. Renslo, A. R.; Luehr, G. W.; Gordeev, M. F. Bioorg. Med. Chem. 2006, 14, 4227.
4. (a) Jiang, H. F.; Zhao, J. W.; Wang, A. Z. Synthesis 2008, 5, 763; (b) Fournier, J.;
Bruneau, C.; Dixneuf, P. H. Tetrahedron Lett. 1990, 31, 1721; (c) Gu, Y. L.; Zhang,
Q. H.; Duan, Z. Y.; Zhang, J.; Zhang, S. G.; Deng, Y. Q. J. Org. Chem. 2005, 70, 7376;
(d) Zhang, Q. H.; Shi, F.; Gu, Y. L.; Yang, J.; Deng, Y. Q. Tetrahedron Lett. 2005, 46,
5907.
5. (a) Shi, M.; Shen, Y. M.; Chen, Y. J. Heterocycles 2002, 57, 245; (b) Sisido, K.;
Hukuoka, K.; Tuda, M.; Nozaki, H. J. Org. Chem. 1962, 27, 2663; (c) Easton, N. R.;
Cassady, D. R.; Dillard, R. D. J. Org. Chem. 1962, 27, 2927; (d) Shachat, N.; Bagnell,
J. J., Jr. J. Org. Chem. 1963, 28, 991.
6. Ritter, S.; Horino, Y.; Lex, J.; Schmalz, H. Synlett 2006, 3309.
7. Ramesh, R.; Chandrasekaran, Y.; Megha, R.; Chandrasekaran, S. Tetrahedron
2007, 63, 9153.
8.
A
15 mL polytetrafluoroethylene (PTFE) reaction vessel was charged with
catalyst (0.1 mmol), internal propargylic alcohol (2 mmol), and amine
(2 mmol). The vessel was fixed into stainless autoclave in pressure
a
a
regulating system. The autoclave was sealed. Liquid carbon dioxide was
introduced from a cylinder, and it reacted at the selected temperature under
magnetic stir for the required reaction time. When the reaction was completed,
the vessel was cooled with an ice-bath, and the pressure was released slowly to
atmospheric pressure. The residual was flushed with 3 Â 10 mL diethyl ether.
The products were purified by column chromatography (gel, petroleum ether/
ethyl acetate, 6:1), and were characterized by 1H NMR, 13C NMR, and MS.
4-Benzylidene-3,5-dibutyl-5-ethyloxazolidin-2-one (3a, Z/E mixture): IR (KBr,
m
/cmÀ1): 2959, 2929, 2873, 1768, 1672; 1H NMR (400 MHz, CDCl3) d (ppm):
0.82–0.86 (m, 3H), 0.94–0.98 (m, 6H), 1.34–1.40 (m, 6H), 1.62–1.64 (m, 6H),
3.26–3.30 (t, J = 7.6 Hz, 2H), [3.50–3.56 (t, J = 7.4 Hz, 2H)], 5.40 (s, 1H), [5.79 (s,
1H)], 7.12–7.17 (m, 3H), 7.24–7.31 (m, 2H); 13C NMR (100 MHz, CDCl3) d (ppm):
7.1, 13.3, 13.9, 20.1, 22.4, 24.8, 28.9, 31.9, 38.4, 41.1, 88.4, 99.0, 127.0, 127.8,
128.1, 129.3, 129.7, 134.9, 140.5, 157.2; MS (EI, 70 eV): m/z (%) = 315 [M+] (32),
259 (100), 244 (22), 224 (21), 202 (32), 180 (25), 145 (8), 117 (15), 91 (16), 57
9. Yamada, W.; Sugawara, Y.; Cheng, H. M.; Ikeno, T.; Yamada, T. Eur. J. Org. Chem.
2007, 2604.